Results 101 to 110 of about 2,804,111 (259)
Elimination of pain improves specificity of clinical diagnostic criteria for adult chronic rhinosinusitis [PDF]
, 2017 Objective Determine whether the elimination of pain improves accuracy of clinical diagnostic criteria for adult chronic rhinosinusitis. Study Design Retrospective cohort study.
DiNardo, Laurence J. +4 more
core +2 more sources
Headache, 2019 To assess the effects of migraine on important life domains and compare differences between respondents with episodic and chronic migraine and between sexes.
D. Buse +6 more
semanticscholar +1 more source
, 2013 Migraine is a common disabling headache disorder characterized by recurrent episodes sometimes preceded or accompanied by focal neurological symptoms called aura. The relation between two subtypes, migraine without aura (MWoA) and migraine with aura (MWA)
Dahlem, Markus A.
core +1 more source
Migraine and vascular disease biomarkers: A population-based case-control study. [PDF]
, 2018 Background The underpinnings of the migraine-stroke association remain uncertain, but endothelial activation is a potential mechanism. We evaluated the association of migraine and vascular disease biomarkers in a community-based population.
Ferrari, Michel D. +9 more
core +2 more sources
Management of Chronic Migraine in Children and Adolescents: Where are We in 2022?
Pediatric Health, Medicine and Therapeutics, 2022 Robert C Gibler,1 Kaelynn E Knestrick,1 Brooke L Reidy,1,2 Daniel N Lax,3,4 Scott W Powers1,2,4 1Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA; 2Department of Pediatrics ...
Gibler RC +4 more
doaj
A 2 years prospective evaluation study on onabotulinumtoxinA 195 U in chronic migraine [PDF]
, 2015 Background: OnabotulinumtoxinA (Botox®) is the first and so far the only treatment to receive a specific license for prevention of chronic migraine (CM). In our Headache Clinic the therapy with onabotulinumtoxinA is routinely administered to CM patients
D'Alonzo, Lidia +3 more
core +2 more sources
Erenumab in chronic migraine with medication overuse
Neurology, 2019 Objective To determine the effect of erenumab, a human anti-calcitonin gene-related peptide receptor monoclonal antibody, in patients with chronic migraine and medication overuse.
S. Tepper +10 more
semanticscholar +1 more source
Arquivos de Neuro-Psiquiatria, 2008 This study has evaluated depression in patients with episodic migraine (n=98), chronic migraine without medication overuse (n=23), and chronic migraine with medication overuse (n=57).
Renan Barros Domingues +6 more
doaj +1 more source
Loneliness and Migraine Self-Management: A Cross-Sectional Assessment
Journal of Primary Care & Community Health, 2020 Background: Chronic illness is often comorbid with the psychological state of loneliness. Models of care for patients who experience chronic migraines may often lack an understanding of psychosocial influences of the illness.
Jacob Z. Lui +4 more
doaj +1 more source
Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2). [PDF]
, 2019 BACKGROUND: Patients with high-frequency episodic migraine (HFEM) have a greater disease burden than those with low-frequency episodic migraine (LFEM).
Day, Katie A. +4 more
core +1 more source